Stockreport

Inovio Pharmaceuticals Says FDA Accepts Biologics License Application for INO-3107 for Standard Review; Shares Fall [Yahoo! Finance]

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF Inovio Pharmaceuticals (INO) said Monday that the US Food and Drug Administration has accepted its b [Read more]